文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

急诊药师驱动的抗生素再给药

Pharmacist driven antibiotic redosing in the emergency department.
PubMed 文献 · Am J Emerg Med · 2021-07-21
一句话结论扩展急诊药师执业范围可显著减少急诊滞留患者后续抗生素给药重大延迟,并降低住院死亡率。

单中心前后准实验研究,纳入急诊接受初始抗生素且判定为高危的成人患者,扩展急诊药师执业范围后由药师在初始医嘱后24小时内重新开具后续抗生素。干预组后续抗生素给药重大延迟发生率为13%,对照组为48%(p<0.01);干预组97%患者在急诊滞留期间接受后续抗生素,对照组65%(p<0.01);干预组住院死亡率3%,对照组11%(p=0.02)。

要点

  • 高危成人急诊患者接受初始抗生素后,由急诊药师在24小时内重新开具后续剂量,重大延迟从48%降至13%(p<0.01)。
  • 6小时间隔抗生素重大延迟从39%降至13%,8小时间隔从60%降至8%,12小时间隔无统计学显著差异(19% vs 5%)。
  • 干预组97%患者在急诊滞留期间接受后续抗生素,对照组仅65%(p<0.01)。
  • 干预组住院死亡率3%,对照组11%(p=0.02),但研究设计为前后准实验,不能确立因果关系。

适用人群与场景

  • 成人患者,在急诊接受初始抗生素剂量且被判定为高危;后续抗生素剂量由急诊药师在初始医嘱后最多24小时内重新开具,取决于急诊停留时间。
  • 研究场景为单中心三级学术医疗中心急诊科;历史对照组为前一年回顾性病历审查病例。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 第一步:急诊患者接受初始抗生素剂量并被判定为高危。
  • 第二步:扩展执业范围的急诊药师在初始医嘱后最多24小时内重新开具后续抗生素剂量,取决于急诊停留时间。
  • 原文未提及具体药物剂量、给药途径、频次或目标值。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:前后准实验研究,单中心三级学术医疗中心,2019年11月至2020年3月,比较扩展急诊药师执业范围实施前后。
  • 样本量:共181例参与者纳入。
  • 主要终点:后续抗生素给药重大延迟在干预组发生率为13%,对照组为48%(p<0.01)。
  • 关键次要终点:6小时间隔抗生素延迟干预组13% vs 对照组39%;8小时间隔干预组8% vs 对照组60%;12小时间隔干预组5% vs 对照组19%(无统计学显著差异)。
  • 干预组97%患者在急诊滞留期间接受后续抗生素剂量,对照组65%(p<0.01)。
  • 不良事件/安全性:干预组住院死亡率3%,对照组11%(p=0.02)。

证据类型、等级与局限

  • 证据类型:前后准实验研究(非随机对照试验)。
  • 局限:单中心、前后设计、历史对照为回顾性病历审查,可能存在混杂偏倚;原文未提供证据等级或推荐强度。

对床旁实践的改变

  • 在高危成人急诊患者接受初始抗生素后,可由扩展执业范围的急诊药师在24小时内重新开具后续抗生素,以减少给药重大延迟。
  • 该做法在6小时和8小时给药间隔的抗生素中显示减少延迟,12小时间隔未显示统计学显著差异。
  • 研究为单中心前后准实验,住院死亡率下降为关联性结果,不能直接推断因果关系;适用人群限于原文定义的高危成人急诊患者。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Determine whether an expanded emergency medicine (EM) pharmacist scope of practice reduces the frequency of major delays in subsequent antibiotic administration in patients boarded in the emergency department (ED).

METHODS: A pre-post, quasi-experimental study conducted from November 2019-March 2020 at a single-center tertiary academic medical center following the implementation of an expanded EM pharmacist scope of practice. Adult patients were included if they received an initial antibiotic dose in the ED and deemed to be high-risk. Subsequent antibiotic doses were reordered by EM pharmacists for up to 24-h after the initial order pending ED length of stay (LOS). The historical control group consisted of retrospective chart review of cases from the previous year.

RESULTS: The study identified that of the 181 participants enrolled, major delays in subsequent antibiotic administration occurred in 13% of the intervention group and 48% of the control group (p < 0.01). When compared to the control group, the intervention group had a significant decrease in the number of delays among antibiotics dosed at 6-h (39% vs 13%) and 8-h (60% vs 8%) intervals. For antibiotics dosed at 12-h intervals, no statistically significant difference was observed between the control and intervention groups respectively (19% vs 5%). A statistically significant lower incidence of in-hospital mortality was observed in the intervention group (3% vs 11%, p = 0.02). In the intervention group, 97% of patients received subsequent antibiotic doses while boarded in the ED, compared to 65% in the control group (<0.01).

CONCLUSION: Expanding EM pharmacist scope of practice was associated with a significant reduction in the frequency of major delays in subsequent antibiotic administration as well as a decreased incidence of hospital mortality.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Payne-Cardona M, San Luis VA, Aazami R, et al. Pharmacist driven antibiotic redosing in the emergency department. Am J Emerg Med. 2021. PMID: 34365066. doi:10.1016/j.ajem.2021.07.039

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。